MicroRNA expression levels as diagnostic biomarkers for intraductal papillary mucinous neoplasm.

Related Articles

MicroRNA expression levels as diagnostic biomarkers for intraductal papillary mucinous neoplasm.

Oncotarget. 2017 May 08;:

Authors: Wang L, Zheng J, Sun C, Wang L, Jin G, Xin L, Jin Z, Wang D, Li Z

Abstract
Intraductal papillary mucinous neoplasms (IPMNs) are deadly exocrine mucinous tumors. Currently the molecular features and diagnostic markers of IPMNs are not well understood. In this study, we performed microRNA (miRNA) profiling assays to study the potential roles of miRNAs in IPMNs using 78 cases of IPMN patients and controls. When comparing the miRNA expression between IPMN patient samples and controls, we found that miR-210, miR-223, miR-221, miR-155 and miR-187 were differentially expressed in normal pancreas and IPMNs. We further studied the miRNA expression profiles in different pancreatic diseases and identified miRNA features that are associated with Chronic pancreatitis (CP), IPMN, and Pancreatic ductal adenocarcinoma (PDAC). Therefore, these miRNAs might serve as new risk biomarkers of IPMN and could be useful for future targeted therapies.

PMID: 28545033 [PubMed - as supplied by publisher]

http://ift.tt/2rnX3PY